Professor Patrick Chinnery, an expert in diseases that affect mitochondria – the ‘batteries’ that power our cells – has been appointed as Professor of Neurology and Head of the Department of Clinical Neurosciences at the University of Cambridge. He will take up his appointment on 1 October.
The Academy of Medical Sciences has announced the election of its new Fellows, including five Cambridge University academics.
Scientists in Cambridge have found hidden signatures in the brains of people in a vegetative state, which point to networks that could support consciousness even when a patient appears to be unconscious and unresponsive. The study could help doctors identify patients who are aware despite being unable to communicate.
Research raises possibility of devices in the future to help some patients in a vegetative state interact with the outside world.
Critical insight provided into the disease mechanisms behind multiple sclerosis.
The British Academy has today announced the scholars elected for this year’s Fellowships in recognition of their contribution to the humanities and social sciences.
A major new drive to understand, diagnose and treat Alzheimer’s disease has begun in Cambridge.
The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.
Cambridge neurologists have shown that an antibody used to treat leukaemia also limits and repairs the damage in multiple sclerosis.
© 2026 University of Cambridge